Literature DB >> 25465091

Arterial tissue and plasma concentration of enzymatic-driven oxysterols are associated with severe peripheral atherosclerotic disease and systemic inflammatory activity.

V W M Virginio1, V S Nunes, F A Moura, F H Menezes, N A Andreollo, F Rogerio, D Z Scherrer, E C R Quintão, E Nakandakare, O Petrucci, W Nadruz-Junior, E C de Faria, A C Sposito.   

Abstract

INTRODUCTION: Cholesterol undergoes oxidation via both enzymatic stress- and free radical-mediated mechanisms, generating a wide range of oxysterols. In contrast to oxidative stress-driven metabolites, enzymatic stress-derived oxysterols are scarcely studied in their association with atherosclerotic disease in humans.
METHODS: 24S-hydroxycholesterol (24S-HC), 25-hydroxycholesterol (25-HC), and 27-hydroxycholesterol (27-HC) were assessed in plasma and arteries with atherosclerotic plaques from 10 patients (54-84 years) with severe peripheral artery disease (PAD) as well as arteries free of atherosclerotic plaques from 13 individuals (45-78 years, controls).
RESULTS: Plasma 25-HC was higher in PAD individuals than in controls (6.3[2] vs. 3.9[1.9] ng/mgCol; p = 0.004). 24S-HC and 27-HC levels were, respectively, five- and 20-fold higher in the arterial tissue of PAD individuals than in those of the controls (p = 0.016 and p = 0.001). Plasma C-reactive protein correlated with plasma 24-HC (r = 0.51; p = 0.010), 25-HC (r = 0.75; p < 0.001), 27-HC (r = 0.48; p = 0.015), and with tissue 24S-HC (r = 0.4; p = 0.041) and 27-HC (r = 0.46; p = 0.023).
CONCLUSION: Arterial intima accumulation of 27-HC and 24S-HC is associated with advanced atherosclerotic disease and systemic inflammatory activity in individuals with severe PAD.

Entities:  

Keywords:  24S-hydroxycholesterol; atherosclerosis; oxysterols; peripheral artery disease

Mesh:

Substances:

Year:  2014        PMID: 25465091     DOI: 10.3109/10715762.2014.992894

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  9 in total

Review 1.  The role of oxysterols in vascular ageing.

Authors:  Simona Gargiulo; Paola Gamba; Gabriella Testa; Gabriella Leonarduzzi; Giuseppe Poli
Journal:  J Physiol       Date:  2016-01-19       Impact factor: 5.182

Review 2.  27-Hydroxycholesterol, an endogenous selective estrogen receptor modulator.

Authors:  Sisi He; Erik R Nelson
Journal:  Maturitas       Date:  2017-07-31       Impact factor: 4.342

Review 3.  The Lipid-lowering Effects and Associated Mechanisms of Dietary Phytosterol Supplementation.

Authors:  Jerad H Dumolt; Todd C Rideout
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 4.  A review of the pathophysiology and potential biomarkers for peripheral artery disease.

Authors:  Smriti Murali Krishna; Joseph V Moxon; Jonathan Golledge
Journal:  Int J Mol Sci       Date:  2015-05-18       Impact factor: 5.923

5.  Simvastatin reduces circulating oxysterol levels in men with hypercholesterolaemia.

Authors:  Irundika H K Dias; Ivana Milic; Gregory Y H Lip; Andrew Devitt; M Cristina Polidori; Helen R Griffiths
Journal:  Redox Biol       Date:  2018-02-17       Impact factor: 11.799

Review 6.  Pathophysiology of chronic limb ischemia.

Authors:  F Simon; A Oberhuber; N Floros; P Düppers; H Schelzig; M Duran
Journal:  Gefasschirurgie       Date:  2018-04-10

7.  The Effect of Orlistat on Sterol Metabolism in Obese Patients.

Authors:  Yu-Jin Kwon; Go Eun Kwon; Hye Sun Lee; Man Ho Choi; Ji-Won Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-23       Impact factor: 5.555

8.  Dietary docosahexaenoic acid supplementation prevents the formation of cholesterol oxidation products in arteries from orchidectomized rats.

Authors:  Diva M Villalpando; Mibsam M Rojas; Hugo S García; Mercedes Ferrer
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

9.  Oxysterols Increase Inflammation, Lipid Marker Levels and Reflect Accelerated Endothelial Dysfunction in Experimental Animals.

Authors:  Tomasz Wielkoszyński; Jolanta Zalejska-Fiolka; Joanna K Strzelczyk; Aleksander J Owczarek; Armand Cholewka; Marcin Furmański; Agata Stanek
Journal:  Mediators Inflamm       Date:  2018-03-11       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.